Acorn Biolabs

Acorn Biolabs offers a non-invasive service that collects and cryogenically preserves live stem cells from hair follicles. The company enables individuals to store their own viable autologous cells indefinitely for potential use in future regenerative medicine applications such as anti-aging therapies, cosmetic skin/hair rejuvenation, injury recovery, and possibly disease treatment. Their business model centers on direct-to-consumer services via clinics with an annual subscription fee. They have recently raised $11M CAD Series A funding to expand commercialization efforts and develop new personalized topical products leveraging clients' own preserved cells. No current evidence of late-stage therapeutic product development or regulatory submissions.